Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Life Sciences

PDF

Thomas Jefferson University

College of Life Sciences Faculty Papers

Series

2020

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

From Gene To Function: A Safe Laboratory Exercise Promoting The Learning Of The Central Dogma Of Biology For The Undergraduate Biology Curriculum., Manuela Tripepi, Morgan Clear, Jack Lyons Bondi, Elvira Brunelli, Arianna Berardi Aug 2020

From Gene To Function: A Safe Laboratory Exercise Promoting The Learning Of The Central Dogma Of Biology For The Undergraduate Biology Curriculum., Manuela Tripepi, Morgan Clear, Jack Lyons Bondi, Elvira Brunelli, Arianna Berardi

College of Life Sciences Faculty Papers

No abstract provided.


Levetiracetam Versus Phenytoin For The Treatment Of Established Status Epilepticus: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials., Linjie Li, Yu Zhang, Lu Jia, Desheng Jia, Andrew Faramand, Weelic Chong, Yuan Fang, Lu Ma, Fang Fang Mar 2020

Levetiracetam Versus Phenytoin For The Treatment Of Established Status Epilepticus: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials., Linjie Li, Yu Zhang, Lu Jia, Desheng Jia, Andrew Faramand, Weelic Chong, Yuan Fang, Lu Ma, Fang Fang

College of Life Sciences Faculty Papers

OBJECTIVES: To compare the efficacy and safety of levetiracetam and phenytoin for the treatment of established status epilepticus.

METHODS: In this systematic review, we searched Medline, Embase, and Cochrane databases from their inception with no language restrictions until May 8, 2019 and updated on February 5, 2020, for randomized controlled trials comparing the efficacy and safety of levetiracetam and phenytoin for the treatment of established status epilepticus. A Meta-analysis was conducted to calculate the risk ratio (RR) using random-effects models.

RESULTS: We identified 7 trials with a total of 1028 participants. Levetiracetam was not associated with an increased rate of …